Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
2,668
+19
+0.7% +$2.22K 0.09% 58
2026
Q1
$319K Sell
2,649
-518
-16% -$59.8K 0.09% 58
2025
Q4
$333K Buy
3,167
+24
+0.8% +$2.25K 0.1% 59
2025
Q3
$264K Buy
3,143
+26
+0.8% +$2.14K 0.08% 69
2025
Q2
$247K Buy
3,117
+25
+0.8% +$1.99K 0.08% 70
2025
Q1
$278K Buy
3,092
+48
+2% +$4.48K 0.09% 53
2024
Q4
$303K Buy
+3,044
New +$314K 0.1% 49

Other funds holding MRK

Regimen Wealth's MRK Position: Q2 2026 in Review

Regimen Wealth increased its Merck (MRK) stake by 0.72% in Q2 2026, buying an estimated $2.22K and bringing the position to 2,668 shares worth $343K. The position accounts for 0.09% of the portfolio, ranked #58.

Regimen Wealth first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Regimen Wealth held 2,668 shares of Merck worth $343K as of Q2 2026.
  • Regimen Wealth bought 19 Merck shares in Q2 2026, an estimated $2.22K.
  • Merck made up 0.09% of Regimen Wealth's portfolio in Q2 2026, its #58 holding.
  • Regimen Wealth first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Regimen Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.